Smith & Nephew SNATS Free Cash Flow 2010-2023 | SNN
- Smith & Nephew SNATS free cash flow for the quarter ending December 31, 2023 was , a year-over-year.
- Smith & Nephew SNATS free cash flow for the twelve months ending December 31, 2023 was , a year-over-year.
- Smith & Nephew SNATS annual free cash flow for 2023 was $0.181B, a 64.55% increase from 2022.
- Smith & Nephew SNATS annual free cash flow for 2022 was $0.11B, a 76.55% decline from 2021.
- Smith & Nephew SNATS annual free cash flow for 2021 was $0.469B, a 4.67% decline from 2020.
Smith & Nephew SNATS Annual Free Cash Flow | |
---|---|
2023 | 181.00 |
2022 | 110.00 |
2021 | 469.00 |
2020 | 492.00 |
2019 | 760.00 |
2018 | 584.00 |
2017 | 714.00 |
2016 | 457.00 |
2015 | 672.00 |
2014 | 328.00 |
2013 | 527.00 |
2012 | 637.00 |
2011 | 521.00 |
2010 | 552.00 |
2009 | 401.00 |
Smith & Nephew SNATS Quarterly Free Cash Flow | |
---|---|
2023-12-31 | |
2022-12-31 | |
2022-06-30 | |
2021-12-31 | |
2021-06-30 | |
2020-12-31 | |
2020-06-30 | |
2019-12-31 | |
2019-06-30 | |
2018-12-31 | |
2018-06-30 | |
2017-12-31 | |
2017-06-30 | |
2016-12-31 | |
2015-12-31 | |
2015-06-30 | |
2014-12-31 | 308.00 |
2014-09-30 | 124.00 |
2014-06-30 | 233.00 |
2014-03-31 | 26.00 |
2013-12-31 | 527.00 |
2013-09-30 | 331.00 |
2013-06-30 | 206.00 |
2013-03-31 | 137.00 |
2012-12-31 | 637.00 |
2012-09-30 | 566.00 |
2012-06-30 | 268.00 |
2012-03-31 | 96.00 |
2011-12-31 | 521.00 |
2011-09-30 | 413.00 |
2011-06-30 | 275.00 |
2011-03-31 | 139.00 |
2010-12-31 | 552.00 |
2010-09-30 | 402.00 |
2010-06-30 | 250.00 |
2010-03-31 | 131.00 |
2009-12-31 | 401.00 |
2009-09-30 | 216.00 |
2009-06-30 | 64.00 |
2009-03-31 | 53.00 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $11.375B | $5.549B |
Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $179.548B | 23.51 |
Stryker (SYK) | United States | $125.611B | 30.08 |
Medtronic (MDT) | Ireland | $112.214B | 15.89 |
Boston Scientific (BSX) | United States | $110.560B | 35.22 |
EssilorLuxottica (ESLOY) | France | $102.987B | 0.00 |
Lonza Group Ag (LZAGY) | Switzerland | $43.408B | 0.00 |
Haleon (HLN) | United Kingdom | $38.858B | 28.37 |
ResMed (RMD) | United States | $32.134B | 30.17 |
Terumo (TRUMY) | Japan | $26.594B | 37.56 |
Koninklijke Philips (PHG) | Netherlands | $25.426B | 19.70 |
Zimmer Biomet Holdings (ZBH) | United States | $24.492B | 15.64 |
Baxter (BAX) | United States | $17.846B | 12.69 |
Insulet (PODD) | United States | $12.897B | 57.19 |
Demant (WILYY) | Denmark | $11.282B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $8.326B | 27.23 |
BellRing Brands (BRBR) | United States | $7.474B | 35.15 |
Lantheus Holdings (LNTH) | United States | $5.744B | 14.31 |
Haemonetics (HAE) | United States | $4.838B | 23.94 |
GN Store Nord (GNNDY) | Denmark | $4.400B | 24.71 |
Perrigo (PRGO) | Ireland | $4.027B | 12.21 |
Prestige Consumer Healthcare (PBH) | United States | $3.230B | 15.37 |
Envista Holdings (NVST) | United States | $3.140B | 12.96 |
Neogen (NEOG) | United States | $2.961B | 28.48 |
Maravai LifeSciences Holdings (MRVI) | United States | $2.851B | 0.00 |
QuidelOrtho (QDEL) | United States | $2.839B | 15.76 |
Green Thumb Industries (GTBIF) | United States | $2.604B | 51.58 |
TG Therapeutics (TGTX) | United States | $2.547B | 71.65 |
ICU Medical (ICUI) | United States | $2.516B | 22.20 |
Agios Pharmaceuticals (AGIO) | United States | $1.884B | 0.00 |
LeMaitre Vascular (LMAT) | United States | $1.782B | 52.23 |
Verano Holdings (VRNOF) | United States | $1.676B | 0.00 |
Warby Parker (WRBY) | United States | $1.654B | 0.00 |
InMode (INMD) | Israel | $1.596B | 8.48 |
Owens & Minor (OMI) | United States | $1.377B | 12.00 |
AdaptHealth (AHCO) | United States | $1.317B | 9.79 |
National Vision Holdings (EYE) | United States | $1.221B | 38.85 |
AtriCure (ATRC) | United States | $1.062B | 0.00 |
BioLife Solutions (BLFS) | United States | $1.005B | 0.00 |
Canopy Growth (CGC) | Canada | $0.853B | 0.00 |
Evolus (EOLS) | United States | $0.840B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.738B | 15.72 |
Cresco Labs (CRLBF) | United States | $0.736B | 0.00 |
Quanterix (QTRX) | United States | $0.659B | 0.00 |
Valneva SE (VALN) | France | $0.616B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.614B | 14.43 |
PetIQ (PETQ) | United States | $0.593B | 19.38 |
Surmodics (SRDX) | United States | $0.500B | 31.30 |
Jin Medical (ZJYL) | China | $0.474B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.472B | 0.00 |
ZimVie (ZIMV) | United States | $0.465B | 39.60 |
Aurora Cannabis (ACB) | Canada | $0.404B | 0.00 |
OraSure Technologies (OSUR) | United States | $0.365B | 11.74 |
Cerus (CERS) | United States | $0.361B | 0.00 |
Biote (BTMD) | United States | $0.350B | 8.06 |
Zynex (ZYXI) | United States | $0.336B | 45.91 |
Sanara MedTech (SMTI) | United States | $0.281B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.276B | 27.31 |
TriSalus Life Sciences (TLSI) | United States | $0.272B | 0.00 |
MacroGenics (MGNX) | United States | $0.267B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.243B | 15.31 |
Veru (VERU) | United States | $0.208B | 0.00 |
Organigram Holdings (OGI) | Canada | $0.206B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.201B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.200B | 0.00 |
Omeros (OMER) | United States | $0.191B | 0.00 |
High Tide (HITI) | Canada | $0.173B | 0.00 |
Eagleford Energy (GRUSF) | United States | $0.169B | 81.00 |
InterCure (INCR) | Israel | $0.154B | 26.00 |
Quipt Home Medical (QIPT) | United States | $0.138B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.132B | 0.00 |
FitLife Brands (FTLF) | United States | $0.128B | 18.14 |
Cellectar Biosciences (CLRB) | United States | $0.113B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.096B | 0.00 |
MariMed (MRMD) | United States | $0.094B | 0.00 |
Brainsway (BWAY) | Israel | $0.091B | 0.00 |
Fonar (FONR) | United States | $0.091B | 7.82 |
Chimerix (CMRX) | United States | $0.088B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.081B | 0.00 |
Safety Shot (SHOT) | United States | $0.071B | 0.00 |
Zevia PBC (ZVIA) | United States | $0.069B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.060B | 3.91 |
Apyx Medical (APYX) | United States | $0.055B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.055B | 0.00 |
Cytosorbents (CTSO) | United States | $0.053B | 0.00 |
Bright Green (BGXX) | United States | $0.043B | 0.00 |
United-Guardian (UG) | United States | $0.042B | 15.20 |
Modular Medical (MODD) | United States | $0.037B | 0.00 |
ImmuCell (ICCC) | United States | $0.037B | 0.00 |
Exagen (XGN) | United States | $0.032B | 0.00 |
Nephros (NEPH) | United States | $0.024B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.019B | 0.00 |
Agape ATP (ATPC) | $0.019B | 0.00 | |
Flora Growth (FLGC) | United States | $0.016B | 0.00 |
FSD PHARMA (HUGE) | Canada | $0.014B | 0.00 |
GlucoTrack (GCTK) | United States | $0.013B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.010B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.009B | 0.00 |
NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.004B | 0.00 |
Sharps Technology (STSS) | United States | $0.004B | 0.00 |
Senestech (SNES) | United States | $0.004B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.002B | 0.00 |
Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
Smart For Life (SMFL) | United States | $0.000B | 0.00 |
Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
SNDL (SNDL) | Canada | $0.000B | 0.00 |